Biohaven (BHVN) News Today → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free BHVN Stock Alerts $38.45 +1.37 (+3.69%) (As of 05:17 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 3:59 PM | marketbeat.comBiohaven (NYSE:BHVN) Shares Gap Down to $37.08Biohaven (NYSE:BHVN) Shares Gap Down to $37.08May 16 at 8:09 AM | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Short Interest UpdateBiohaven Ltd. (NYSE:BHVN - Get Free Report) was the recipient of a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 9,630,000 shares, an increase of 8.1% from the April 15th total of 8,910,000 shares. Based on an average trading volume of 1,300,000 shares, the days-to-cover ratio is currently 7.4 days.May 16 at 5:52 AM | americanbankingnews.comJohn W. Childs Buys 28,500 Shares of Biohaven Ltd. (NYSE:BHVN) StockMay 16 at 2:42 AM | americanbankingnews.comAnalysts Issue Forecasts for Biohaven Ltd.'s FY2024 Earnings (NYSE:BHVN)May 16 at 2:04 AM | americanbankingnews.comBiohaven Ltd. (NYSE:BHVN) Receives Consensus Recommendation of "Buy" from BrokeragesMay 16 at 1:32 AM | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Given Average Rating of "Buy" by AnalystsBiohaven Ltd. (NYSE:BHVN - Get Free Report) has been given an average rating of "Buy" by the eight brokerages that are currently covering the company, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy recommendation. The average 12 month target price among brokers that havMay 15 at 8:37 PM | marketbeat.comNicholas Investment Partners LP Has $5.12 Million Stock Position in Biohaven Ltd. (NYSE:BHVN)Nicholas Investment Partners LP reduced its position in Biohaven Ltd. (NYSE:BHVN - Free Report) by 79.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 119,512 shares of the company's stock after selling 4May 15 at 11:12 AM | finance.yahoo.comDirector Gregory Bailey Acquires 15,000 Shares of Biohaven Ltd (BHVN)May 15 at 8:12 AM | marketbeat.comFY2024 Earnings Estimate for Biohaven Ltd. (NYSE:BHVN) Issued By Cantor FitzgeraldBiohaven Ltd. (NYSE:BHVN - Free Report) - Investment analysts at Cantor Fitzgerald dropped their FY2024 earnings per share estimates for Biohaven in a report issued on Monday, May 13th. Cantor Fitzgerald analyst C. Duncan now anticipates that the company will post earnings of ($7.46) per share foMay 15 at 7:19 AM | insidertrades.comInsider Buying: Biohaven Ltd. (NYSE:BHVN) Director Buys 28,500 Shares of StockMay 15 at 3:28 AM | americanbankingnews.comHC Wainwright Cuts Biohaven (NYSE:BHVN) Price Target to $59.00May 15 at 2:36 AM | americanbankingnews.comBiohaven (NYSE:BHVN) Shares Up 9.4% on Insider Buying ActivityMay 14 at 8:06 PM | markets.businessinsider.comBuy Rating Affirmed on Biohaven Ltd. Amidst Pipeline Potential and Upcoming DevelopmentsMay 14 at 1:30 PM | marketbeat.comBiohaven (NYSE:BHVN) Trading 9.4% Higher on Insider Buying ActivityBiohaven (NYSE:BHVN) Trading Up 9.4% on Insider Buying ActivityMay 14 at 8:55 AM | marketbeat.comInsider Buying: Biohaven Ltd. (NYSE:BHVN) Director Acquires 28,500 Shares of StockBiohaven Ltd. (NYSE:BHVN - Get Free Report) Director John W. Childs bought 28,500 shares of Biohaven stock in a transaction on Monday, May 13th. The shares were purchased at an average cost of $35.17 per share, for a total transaction of $1,002,345.00. Following the acquisition, the director now owns 2,283,341 shares in the company, valued at $80,305,102.97. The purchase was disclosed in a filing with the SEC, which is available at the SEC website.May 14 at 1:22 AM | americanbankingnews.comBiohaven (NYSE:BHVN) Shares Down 2.2% Following Analyst DowngradeMay 13 at 10:45 AM | marketbeat.comBiohaven (NYSE:BHVN) Trading Down 2.2% Following Analyst DowngradeBiohaven (NYSE:BHVN) Trading Down 2.2% Following Analyst DowngradeMay 13 at 8:47 AM | marketbeat.comBiohaven (NYSE:BHVN) PT Lowered to $59.00 at HC WainwrightHC Wainwright cut their target price on shares of Biohaven from $63.00 to $59.00 and set a "buy" rating on the stock in a research note on Monday.May 12, 2024 | americanbankingnews.comBiohaven (NYSE:BHVN) Shares Gap Down to $41.36May 10, 2024 | finanznachrichten.deBiohaven Ltd.: Biohaven Reports First Quarter 2024 Financial Results and Recent Business DevelopmentsMay 10, 2024 | investorplace.comBHVN Stock Earnings: Biohaven Misses EPS for Q1 2024May 9, 2024 | msn.comBiohaven reports Q1 resultsMay 9, 2024 | prnewswire.comBiohaven Reports First Quarter 2024 Financial Results and Recent Business DevelopmentsMay 2, 2024 | finance.yahoo.comBiohaven Ltd. (BHVN)May 1, 2024 | investorplace.comShhh! 3 Secret Biotech Stocks Flying Below Wall Street's RadarApril 28, 2024 | 247wallst.comThese Biotechs and IPOs Inspire Big Insider BuyingApril 26, 2024 | finance.yahoo.comIndependent Director of Biohaven John Childs Buys 3.2% More SharesApril 26, 2024 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Expected to Post FY2024 Earnings of ($6.13) Per ShareBiohaven Ltd. (NYSE:BHVN - Free Report) - Stock analysts at Cantor Fitzgerald lifted their FY2024 EPS estimates for shares of Biohaven in a report issued on Wednesday, April 24th. Cantor Fitzgerald analyst C. Duncan now expects that the company will post earnings of ($6.13) per share for the yearApril 26, 2024 | marketbeat.comJennison Associates LLC Takes $11.40 Million Position in Biohaven Ltd. (NYSE:BHVN)Jennison Associates LLC bought a new position in Biohaven Ltd. (NYSE:BHVN - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 266,391 shares of the company's stock, valued at approximately $11,402,000. Jennison Associates LLC owApril 26, 2024 | msn.com3 Biotech Stocks to Buy on the Dip: April 2024April 26, 2024 | insidertrades.comBiohaven Ltd. (NYSE:BHVN) Director Acquires $999,207.54 in StockApril 25, 2024 | markets.businessinsider.comRBC Capital Keeps Their Buy Rating on Biohaven Ltd. (BHVN)April 25, 2024 | finance.yahoo.comDirector Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN)April 25, 2024 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Director Gregory Bailey Purchases 25,503 SharesBiohaven Ltd. (NYSE:BHVN - Get Free Report) Director Gregory Bailey bought 25,503 shares of Biohaven stock in a transaction on Wednesday, April 24th. The shares were acquired at an average cost of $39.18 per share, with a total value of $999,207.54. Following the completion of the acquisition, the director now owns 1,600,071 shares of the company's stock, valued at approximately $62,690,781.78. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.April 24, 2024 | insidertrades.comBiohaven Ltd. (NYSE:BHVN) Director Acquires $1,999,980.00 in StockApril 23, 2024 | finance.yahoo.comDirector Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN)April 23, 2024 | marketbeat.comBiohaven (NYSE:BHVN) Price Target Raised to $60.00UBS Group raised their price objective on Biohaven from $59.00 to $60.00 and gave the stock a "buy" rating in a research note on Tuesday.April 23, 2024 | marketbeat.comBiohaven (NYSE:BHVN) Shares Gap Up on Insider Buying ActivityBiohaven (NYSE:BHVN) Shares Gap Up on Insider Buying ActivityApril 23, 2024 | marketbeat.comGregory Bailey Buys 48,780 Shares of Biohaven Ltd. (NYSE:BHVN) StockBiohaven Ltd. (NYSE:BHVN - Get Free Report) Director Gregory Bailey acquired 48,780 shares of Biohaven stock in a transaction dated Monday, April 22nd. The stock was purchased at an average price of $41.00 per share, for a total transaction of $1,999,980.00. Following the completion of the acquisition, the director now directly owns 1,574,568 shares in the company, valued at approximately $64,557,288. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.April 19, 2024 | marketbeat.comBiohaven (NYSE:BHVN) Trading Down 4.8%Biohaven (NYSE:BHVN) Stock Price Down 4.8%April 18, 2024 | markets.businessinsider.comMaintaining Buy Rating: Biohaven’s BHV-1300 Shows Promising Efficacy and Safety ProfileApril 18, 2024 | markets.businessinsider.comBiohaven Prices Offering Of $230 Mln Of Shares At $41/share; Stock Down In Pre-MarketApril 18, 2024 | msn.comBiohaven drops 4%, prices $230M share offeringApril 18, 2024 | marketbeat.comCantor Fitzgerald Reiterates Overweight Rating for Biohaven (NYSE:BHVN)Cantor Fitzgerald restated an "overweight" rating on shares of Biohaven in a research report on Thursday.April 18, 2024 | prnewswire.comBiohaven Announces Pricing of $230 Million Public Offering of Common SharesApril 17, 2024 | finance.yahoo.comBiohaven Announces Proposed Public Offering of Common SharesApril 17, 2024 | investing.comBiohaven shares rise on positive early-stage drug dataApril 17, 2024 | investing.comBiohaven retains stock target despite trial delayApril 15, 2024 | seekingalpha.comBiohaven stock slides 15% amid data presentationsApril 15, 2024 | marketbeat.comBiohaven (NYSE:BHVN) Shares Gap Down to $53.08Biohaven (NYSE:BHVN) Shares Gap Down to $53.08 Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Charles Payne Demystifies Options (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. BHVN Media Mentions By Week BHVN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BHVN News Sentiment▼0.180.55▲Average Medical News Sentiment BHVN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BHVN Articles This Week▼284▲BHVN Articles Average Week Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Axsome Therapeutics News Summit Therapeutics News Crinetics Pharmaceuticals News Ultragenyx Pharmaceutical News Prestige Consumer Healthcare News Insmed News HUTCHMED News Xenon Pharmaceuticals News Alkermes News Perrigo News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BHVN) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biohaven Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
